CIK 0000906709 · Non-accelerated filer<br>Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943134940
- Phone
- 4154825300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Other events
- D Other Notice of Sales of Unregistered Securities
- SC 13G Stake Amended Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 10-K Report Annual Report
- 8-K Event Material agreement · Results of operations
- 8-K Event Material agreement · Unregistered share sale
- 4 Open-market sale Chief R&D Officer sold 9,014 shares at $0.68 ($6,130)
- 4 Open-market sale Chief Legal Officer sold 7,606 shares at $0.68 ($5,172)
- 4 Open-market sale President & CEO sold 20,033 shares at $0.68 ($13,622)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Agreement ended · Other events
- SC 13G/A Stake Amended Statement of Ownership
Page 12 of 100 · 1,982 filings